Hemogenyx Pharmaceuticals Plc (HEMO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 12-2022 | 06-2022 | 12-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,085 | 2,533 | 5,799 | 6,841 | 10,564 |
| Other current assets | 80 | 10 | 672 | 8 | 85 |
| TOTAL | $3,165 | $2,595 | $6,472 | $7,139 | $10,648 |
| Non-Current Assets | |||||
| PPE Net | 3,477 | 3,916 | 741 | 797 | 207 |
| Intangibles | 441 | 441 | 491 | 441 | 251 |
| Other Non-Current Assets | 141 | 141 | 139 | 143 | 0 |
| TOTAL | $4,059 | $4,498 | $1,371 | $1,381 | $458 |
| Total Assets | $7,224 | $7,093 | $7,842 | $8,520 | $11,106 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 0 | N/A | 0 | 1,504 |
| Accounts payable and accrued liabilities | 329 | 374 | 963 | 296 | 269 |
| TOTAL | $777 | $748 | $963 | $353 | $1,803 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 34 | 32 | 38 | 24 | 16 |
| TOTAL | $2,817 | $3,101 | $0 | $0 | $0 |
| Total Liabilities | $3,594 | $3,849 | $963 | $353 | $1,803 |
| Shareholders' Equity | |||||
| Common Shares | 9,814 | 9,797 | 9,797 | 9,797 | 9,797 |
| Retained earnings | -21,435 | -17,114 | -14,262 | -13,135 | -11,668 |
| Other shareholders' equity | -5,425 | -6,217 | -5,427 | -5,280 | -5,619 |
| TOTAL | $3,664 | $3,275 | $6,917 | $8,192 | $9,320 |
| Total Liabilities And Equity | $7,258 | $7,125 | $7,880 | $8,545 | $11,123 |